人类蛋白Z作为来自内源性血液凝固抑制系统的第二个已知的血红蛋白结合蛋白
Paula Lindemann1, Marie-T Hopp1
1Bioorganic Chemistry, Chemistry Department, Institute for Integrated Natural Sciences, University of Koblenz, Universitätsstraße 1, 56070, Koblenz, Germany.
Chembiochem : a European journal of chemical biology
|November 28, 2025
概括
血液抗凝剂蛋白Z (PZ) 结合血红素,增强其血栓抑制,但降低其抗凝剂活性. 这种血红蛋白相互作用可能会将PZ转移到前血栓作用,影响血液凝固.
科学领域:
- 生物化学 生物化学
- 血液学 血液学 血液学
- 分子生物学分子生物学
背景情况:
- 蛋白Z (PZ) 是一种依赖维生素K的葡萄糖蛋白,参与抗凝.
- PZ与激活蛋白C (APC) 具有同质性,另一种已知与heme相互作用的抗凝蛋白是heme.
- 凝血抑制剂在血触发效应中的作用仍然在很大程度上未知.
研究的目的:
- 研究Z蛋白与血红蛋白之间的相互作用.
- 为了确定蛋白Z中的潜在的血红素结合部位.
- 确定PZ-heme相互作用对PZ抗凝剂活性的功能后果.
主要方法:
- 在研究和PZ衍生的被用于识别血红素结合部位.
- 进行了蛋白级结合研究以描述PZ-heme相互作用.
- 激活的部分血栓形成时间 (aPTT) 试验被用来评估在血存在时的抗凝功能.
主要成果:
- 在蛋白Z中确定了一个特定的血红素结合部位,具有与APC相似的结合特性.
- 血结合增加了PZ对血栓的抑制作用.
- 在aPTT试验中,血红素抑制了PZ的抗凝功能,这表明了前血栓性倾向.
结论:
- 蛋白Z与血红素直接相互作用,影响其功能.
- 血与PZ结合具有双重效应:增强血栓抑制和降低抗凝.
- 这些发现凸显了PZ在暴露于血红素的条件下可能发挥的前血栓作用,并要求进一步调查血红素对血液凝结的影响.
相关概念视频
Drug Binding to Blood Components
477
When drugs enter systemic circulation, they interact with various components of the blood, including proteins such as human serum albumin (HSA), α1-acid glycoprotein (AAG), lipoproteins, globulins, and red blood cells (RBCs).
HSA is the most abundant plasma protein and is vital in drug binding. It contains distinct drug-binding sites, with different drugs exhibiting affinity for specific sites. There are three main drug-binding domains for HSA: sites I, II, and III. These domains are...
HSA is the most abundant plasma protein and is vital in drug binding. It contains distinct drug-binding sites, with different drugs exhibiting affinity for specific sites. There are three main drug-binding domains for HSA: sites I, II, and III. These domains are...
477
Protein Buffers in Blood Plasma and Cells
3.5K
The human body utilizes protein buffer systems to maintain a stable pH. These systems capitalize on the dual role of amino acids, which can act as acids or bases by accepting or releasing hydrogen ions in response to pH changes. Protein buffer systems are particularly significant in the extracellular fluid (ECF) and intracellular fluid (ICF) of active cells, where structural and functional proteins provide substantial buffering capacity.
Certain amino acids can exist in a zwitterion state at a...
Certain amino acids can exist in a zwitterion state at a...
3.5K
Anticoagulant Drugs: Low-Molecular-Weight Heparins
1.6K
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
1.6K
Extrinsic and Intrinsic Pathways of Hemostasis
11.8K
Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
11.8K
Hemoglobin
7.3K
Hemoglobin is a globular protein made up of four subunits. Two of these subunits are alpha chains, and the other two are beta chains. Each subunit contains a molecule of heme, which has an iron atom and can bind to oxygen. When an oxygen molecule binds to one heme group, it changes the shape of hemoglobin, making it easier for the other heme groups to bind oxygen as well.
When all four heme groups are bound to oxygen, the resulting molecule is called oxyhemoglobin. As a result, arterial blood...
When all four heme groups are bound to oxygen, the resulting molecule is called oxyhemoglobin. As a result, arterial blood...
7.3K
Coagulation
9.5K
The coagulation phase is a critical part of the body's process to prevent blood loss following injury to blood vessels. It involves chemical reactions that form a clot to seal the injured area. The clotting process begins shortly after injury, within 15-20 seconds for severe damage and 1-2 minutes for minor injuries.
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
9.5K


